Protara Therapeutics, Inc. (FRA:1KPA)
4.700
-0.040 (-0.84%)
Last updated: Jan 9, 2026, 8:12 AM CET
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of €264.9 million as of January 9, 2026. Its market cap has increased by 11.39% in one year.
Market Cap
264.90M
Enterprise Value
153.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.70
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from 155.77M to 264.90M, an increase of 70.05%. That is a compound annual growth rate of 9.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 264.90M | 8.89% |
| Dec 31, 2025 | 243.26M | -0.65% |
| Dec 31, 2024 | 244.85M | 1,169.99% |
| Dec 29, 2023 | 19.28M | -31.77% |
| Dec 30, 2022 | 28.25M | -57.63% |
| Dec 31, 2021 | 66.69M | -69.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |